OpenEvidence signs an alliance with Boston Children's Hospital: the goal is to analyze the impact of AI in healthcare
Article excerpt
Highlighted: the sentence this signal was extracted from
Published An unprecedented alliance between the digital platform OpenEvidence and Boston Children's Hospital seeks to find an answer to a key question. How does the actual use of artificial intelligence (AI) tools by doctors relate to the care they offer patients? It was made official through a statement that it will be a multi-year strategic collaboration. The central objective of this agreement is to study on a large scale the real impact that AI tools used at the point of medical care have on professional decisions and clinical care patterns.Also read: Medtronic completes the acquisition of SPR Therapeutics to strengthen its presence in the chronic pain market The alliance will analyze how the daily use of AI influences medical decision-making. To achieve this, it will focus on two general aspects. "This initiative unites Boston Children's deep clinical expertise with OpenEvidence's clinical evidence platform to better understand how healthcare is delivered and help children thrive, all while protecting patient privacy," said John Brownstein, PhD and Chief Innovation Officer at Boston Children's Hospital.Lilly buys AtaiBeckley and enters psychedelic treatments: the operation was valued at 3.8 billion dollars Both parties emphasized that the fundamental pillar of this project: no individual patient data will be accessed or used. Instead, all analysis will be performed...
Keep reading with a free account
The rest of this article, and every signal for OpenEvidence, is in your free account.
